Veru Inc (NASDAQ:VERU) shares were up 9.8% during trading on Wednesday . The stock traded as high as $2.01 and last traded at $2.01, approximately 232,447 shares traded hands during trading. An increase of 4% from the average daily volume of 222,632 shares. The stock had previously closed at $1.83.

Several analysts have recently commented on VERU shares. Cantor Fitzgerald initiated coverage on shares of Veru in a research note on Monday, July 1st. They set an “overweight” rating and a $6.00 price target on the stock. Brookline Capital Management initiated coverage on shares of Veru in a report on Monday, July 29th. They issued a “buy” rating and a $12.00 price objective on the stock. ValuEngine upgraded shares of Veru from a “hold” rating to a “buy” rating in a report on Friday, May 10th. HC Wainwright restated a “buy” rating and issued a $4.50 price objective on shares of Veru in a report on Friday, August 9th. Finally, Zacks Investment Research lowered shares of Veru from a “hold” rating to a “sell” rating in a report on Wednesday. One investment analyst has rated the stock with a sell rating and seven have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $5.71.

The company’s fifty day simple moving average is $2.17 and its two-hundred day simple moving average is $1.74. The company has a quick ratio of 1.20, a current ratio of 1.47 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $130.73 million, a price-to-earnings ratio of -5.15 and a beta of 0.37.

Veru (NASDAQ:VERU) last posted its earnings results on Thursday, August 8th. The company reported ($0.04) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.04). Veru had a negative net margin of 59.68% and a negative return on equity of 50.14%. The company had revenue of $9.73 million for the quarter, compared to analyst estimates of $8.11 million. Equities research analysts expect that Veru Inc will post -0.18 earnings per share for the current year.

In related news, insider Mitchell Shuster Steiner sold 20,000 shares of the firm’s stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $2.25, for a total transaction of $45,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Over the last 90 days, insiders have sold 70,000 shares of company stock worth $152,400. 29.50% of the stock is currently owned by company insiders.

Large investors have recently modified their holdings of the stock. Virtu Financial LLC bought a new position in Veru in the first quarter valued at $95,000. BlackRock Inc. grew its position in Veru by 9.3% in the fourth quarter. BlackRock Inc. now owns 128,766 shares of the company’s stock valued at $180,000 after purchasing an additional 10,956 shares in the last quarter. Geode Capital Management LLC grew its position in Veru by 115.4% in the fourth quarter. Geode Capital Management LLC now owns 215,601 shares of the company’s stock valued at $301,000 after purchasing an additional 115,506 shares in the last quarter. Wedge Capital Management L L P NC bought a new position in Veru in the second quarter valued at $394,000. Finally, Renaissance Technologies LLC grew its position in Veru by 183.1% in the second quarter. Renaissance Technologies LLC now owns 262,160 shares of the company’s stock valued at $558,000 after purchasing an additional 169,550 shares in the last quarter. Institutional investors and hedge funds own 9.20% of the company’s stock.

Veru Company Profile (NASDAQ:VERU)

Veru Inc operates as an oncology and urology biopharmaceutical company. The company operates through two segments, Commercial, and Research and Development. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.

Recommended Story: The components of the Stochastic Momentum Index

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.